Medication info

Clamoxen Neo Syrup (Amoxicillin-Potassium Clavulanate (14:1))

Prescription medicationSyrupOralApproval withdrawn
Ingredient · strength
Amoxicillin Hydrate›54.55g / 100gDilute Potassium Clavulanate›3.9g / 100g
Manufacturer / importer
NBK Pharmaceuticals Co., Ltd.
Appearance
A syrup that dissolves in water with a peculiar odor, in the form of a white to pale yellow powder
Packaging
50 milliliters/bottle
Approval status
Approval withdrawn

MFDS item code 201906647 · Notified 2019.09.23

This product's status changed to Approval withdrawn on 2023.10.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with impaired liver function, and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the beginning of a meal. Administration of this medicine at the beginning of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients aged 3 months or older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in 2 divided doses given every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
NBK Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children

  • Recurrent acute otitis media
  • persistent acute otitis media
  • recurrent acute sinusitis
View approved original text

This medication is used for the treatment of recurrent or persistent acute otitis media and acute sinusitis in pediatric patients. It is particularly effective in children under 2 years of age who have received antibiotics for these conditions within the last 3 months, as well as those attending daycare. This medication effectively treats several harmful bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Therefore, it helps improve the symptoms of acute otitis media and acute sinusitis in pediatric patients with these conditions.

How to take

Adult dose

○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with impaired liver function, and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the beginning of a meal. Administration of this medicine at the beginning of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients aged 3 months or older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in 2 divided doses given every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8 kg: Administer 3.0mL every 12 hours 12 kg: Administer 4.5mL every 12 hours 16 kg: Administer 6.0mL every 12 hours 20 kg: Administer 7.5mL every 12 hours 24 kg: Administer 9.0mL every 12 hours 28 kg: Administer 10.5mL every 12 hours 32 kg: Administer 12.0mL every 12 hours 36 kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.

Precautions

This medication contains the artificial sweetener aspartame, which breaks down into phenylalanine in the body. Hence, it should not be used in patients with the genetic disorder phenylketonuria. The daily intake of aspartame in this medication should be managed to not exceed the recommended daily amount by WHO, and for a 60 kg adult, it should not exceed a maximum of 2.4 g per day. Caution should be exercised when administering this medication to patients with known allergies to its components or beta-lactam antibiotics, those with infectious mononucleosis or lymphocytic leukemia, those with a history of liver dysfunction or jaundice, and those with lactose intolerance or other genetic issues. Patients with impaired liver function or severe renal disease should use this medication cautiously, and those with allergic tendencies, older adults, or those in poor general condition may be at risk for vitamin K deficiency and should be monitored closely. This medication may cause gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain, and in rare cases, liver disease such as hepatitis or cholestatic jaundice may occur. Symptoms of liver dysfunction may arise during or after treatment, so careful observation is necessary. Furthermore, severe allergic reactions such as rash, urticaria, Stevens-Johnson syndrome, or others may appear, and any unusual symptoms should prompt immediate discontinuation and consultation with a physician. Blood abnormalities may also occur infrequently, and neurological symptoms such as dizziness, headaches, and seizures have been reported, so caution should be taken if these symptoms appear. This medication can affect kidney function; hence, patients with renal impairment should undergo regular testing, and in cases of overdose, gastrointestinal symptoms such as vomiting, diarrhea, and abdominal pain may accompany the risk of kidney damage, necessitating proper hydration and management. This medication may interact with other drugs, so patients taking anticoagulants, certain antibiotics, anti-inflammatory drugs, etc., should definitely inform their doctor. Women who are pregnant or nursing should weigh the risks and benefits when using this medication, especially avoiding use during the first trimester of pregnancy. This medicine should not be used in infants under 3 months as safety and efficacy have not been established. Lastly, this medication is ineffective for viral infections and should only be used for treating bacterial infections, and it must be taken exactly as prescribed regarding the duration and dosage. The medication should be shaken well before use and stored in the refrigerator after preparation and used within 7 days.

Side effects

  • Contact dermatitis
  • diaper rash
  • diarrhea
  • vomiting
  • moniliasis
  • rash
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
Show 84 more
  • glossitis
  • black hairy tongue
  • nausea
  • anorexia
  • abdominal pain
  • abdominal distension
  • constipation
  • colonic pain
  • hyperacidity
  • loose stools
  • dry mouth
  • candidiasis
  • antibiotic-induced colitis
  • increased AST
  • increased ALT
  • increased ALP
  • increased LDH
  • elevated serum bilirubin
  • hepatitis
  • cholestatic jaundice
  • pruritus
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • vesicular exfoliative dermatitis
  • acute generalized pustular psoriasis
  • eosinophilia
  • drug reaction (DRESS)
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • reversible leukopenia
  • reversible thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphocytopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • burning sensation
  • increased secretions
  • anxiety
  • restlessness
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • seizures
  • aseptic meningitis
  • acute kidney failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • vitamin K deficiency symptoms
  • vitamin B deficiency symptoms
  • teeth discoloration
  • taste alteration
  • malaise
  • dermatitis
  • oral edema
  • abdominal pain
  • fluid and electrolyte imbalance
  • hyperactivity
  • drowsiness
  • interstitial nephritis
  • acute renal failure
  • hypersensitivity shock
  • skin reactions
  • bleeding
  • pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it must be kept in a cool and dry place between 1 to 25 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

A syrup that dissolves in water with a peculiar odor, in the form of a white to pale yellow powder

Package unit

50 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.